230 Federal Register / Vol. 63, No. 2 / Monday, January 5, 1998 / Notices

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: December 31, 1997.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 97–34239 Filed 12-31-97; 10:42 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Meeting

The National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC) announces the

following workshop.

Name: Workshop on Public and

Occupational Health Concerns at Rocky

Flats, Colorado.

Time and Date: 3 p.m.–9 p.m.,

January 7, 1998.

Place: Doubletree Hotel, 8773 Yates

Drive, Westminster, Colorado 80030–

3678, telephone 303/427–4000.

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 100

people.

Purpose: The purpose of this

workshop is to provide guidance to

public health researchers on the

inclusion of communities in the

planning, conduct, and application of

research.

History has demonstrated, when

medical and public health science is

planned and conducted in the absence

of considering the social context of its

work, people have been harmed. As a

result, society has responded with laws

and regulations to protect human

subjects who participate in research.

Lacking in this discussion has been the

issue of planning and conducting

research that involves and impacts

communities. This workshop will

provide a unique opportunity to open

dialogue between government,

communities, and researchers. This

dialogue should result in a proposed

framework through which CDC

promotes public health, advances

democratic principles, establishes an

ethical basis for community-based

research, enhances scientific credibility,

and provides mechanisms for building

public trust while advancing the science

of public health.

Matters to be Discussed: Agenda items

will include presentations on the Dose

Reconstruction Project, the National

Institute for Occupational Safety and

Health studies, and the Workers

Medical Surveillance project. Time will

be set aside for public comments and

discussions, with Agency staff, followed

by the workshop being divided into

breakout sessions: (1) Environmental

Health Issues and (2) Occupational

Health Issues.

Agenda items are subject to change as

priorities dictate.

Contact Persons for More Information:

Michael J. Sage, Deputy Chief, Radiation

Studies Branch (RSB), or Carolyn M.

Hart, RSB, Division of Environmental

Hazards and Health Effects, NCEH, CDC,

4770 Buford Highway, NE, (F–35),

Atlanta, Georgia 30341–3724, telephone

770/488–7040, FAX 770/488–7044.

Dated: December 30, 1997.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–34238 Filed 12-31-97; 12:53 pm]

BILLING CODE 4163–18–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N–0513]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for public comment on the

proposed collection of certain

information by the agency. Under the

Paperwork Reduction Act of 1995 (the

PRA), Federal agencies are required to

publish notice in the Federal Register

concerning each proposed collection of

information, including each proposed

reinstatement of an existing collection

of information, and to allow 60 days for

public comment in response to the

notice. This notice solicits comments on

provisions concerning orphan drugs.

DATES: Submit written comments on the

collection of information by March 6,

1998.

ADDRESSES: Submit written comments

on the collection of information to the

Dockets Management Branch (HFA–

305), Food and Drug Administration,

12420 Parklawn Dr., rm. 1–23,

Rockville, MD 20857. All comments

should be identified with the docket

number found in brackets in the

heading of this document.

FOR FURTHER INFORMATION CONTACT:

Denver Presley, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1472.

SUPPLEMENTARY INFORMATION: Under the

PRA (44 U.S.C. 3501–3520), Federal

agencies must obtain approval from the

Office of Management and Budget

(OMB) for each collection of

information they conduct or sponsor.

‘‘Collection of information’’ is defined

in 44 U.S.C. 3502(3) and 5 CFR

1320.3(c) and includes agency requests

or requirements that members of the

public submit reports, keep records, or

provide information to a third party.

Section 3506(c)(2)(A) of the PRA (44

U.S.C. 3506(c)(2)(A)) requires Federal

agencies to provide a 60-day notice in

the Federal Register concerning each

proposed collection of information,

including each proposed reinstatement

of an existing collection of information,

before submitting the collection to OMB

for approval. To comply with this

requirement, FDA is publishing notice

of the proposed collection of

information listed below.

With respect to the following

collection of information, FDA invites

comments on: (1) Whether the proposed

collection of information is necessary

for the proper performance of FDA’s

functions, including whether the

information will have practical utility;

(2) the accuracy of FDA’s estimate of the

burden of the proposed collection of

information, including the validity of

the methodology and assumptions used;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques,

when appropriate, and other forms of

information technology.